<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zenotech Laboratories Limited has confirmed to BSE that it is not classified as a 'Large Corporate' (LC) under SEBI's framework for debt securities issuance. The company submitted this disclosure on April 28, 2026, confirming that the requirement to file initial disclosures (Annexures A, B1 and B2) as mandated by SEBI Circular SEBI/HO/DDHS/DDHSRACPOD1/P/CIR/2023/172 dated October 19, 2023, does not apply to them. The filing was signed by Company Secretary Abdul Gafoor Mohammad. This is a routine regulatory compliance filing clarifying the company's status under SEBI's Large Corporate definitions.
This disclosure has no direct impact on shareholders or stock price. It simply confirms the company's non-classification as a Large Corporate, meaning it is not subject to enhanced disclosure requirements for debt issuance. This is neutral from an investment perspective.